These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9570575)
1. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. Ferrante P; Fusi ML; Saresella M; Caputo D; Biasin M; Trabattoni D; Salvaggio A; Clerici E; de Vries JE; Aversa G; Cazzullo CL; Clerici M J Immunol; 1998 Feb; 160(3):1514-21. PubMed ID: 9570575 [TBL] [Abstract][Full Text] [Related]
2. Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis. Trabattoni D; Ferrante P; Fusi ML; Saresella M; Caputo D; Urnovitz H; Cazzullo CL; Clerici M J Neurovirol; 2000 May; 6 Suppl 2():S38-41. PubMed ID: 10871783 [TBL] [Abstract][Full Text] [Related]
3. Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering. Meroni L; Fusi ML; Varchetta S; Biasin M; Rusconi S; Villa ML; De Vries JE; Aversa G; Galli M; Clerici M Clin Immunol; 1999 Sep; 92(3):276-84. PubMed ID: 10479532 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. Isomäki P; Aversa G; Cocks BG; Luukkainen R; Saario R; Toivanen P; de Vries JE; Punnonen J J Immunol; 1997 Sep; 159(6):2986-93. PubMed ID: 9300723 [TBL] [Abstract][Full Text] [Related]
5. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071 [TBL] [Abstract][Full Text] [Related]
6. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. Castro AG; Hauser TM; Cocks BG; Abrams J; Zurawski S; Churakova T; Zonin F; Robinson D; Tangye SG; Aversa G; Nichols KE; de Vries JE; Lanier LL; O'Garra A J Immunol; 1999 Dec; 163(11):5860-70. PubMed ID: 10570270 [TBL] [Abstract][Full Text] [Related]
8. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. Yamasaki H; Ando M; Brazer W; Center DM; Cruikshank WW J Immunol; 1999 Sep; 163(6):3516-23. PubMed ID: 10477626 [TBL] [Abstract][Full Text] [Related]
9. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. Schweitzer AN; Sharpe AH J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334 [TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740 [TBL] [Abstract][Full Text] [Related]
11. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805 [TBL] [Abstract][Full Text] [Related]
12. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns. García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444 [TBL] [Abstract][Full Text] [Related]
13. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. Aversa G; Chang CC; Carballido JM; Cocks BG; de Vries JE J Immunol; 1997 May; 158(9):4036-44. PubMed ID: 9126961 [TBL] [Abstract][Full Text] [Related]
14. Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection. Quiroga MF; Martínez GJ; Pasquinelli V; Costas MA; Bracco MM; Malbrán A; Olivares LM; Sieling PA; García VE J Immunol; 2004 Sep; 173(6):4120-9. PubMed ID: 15356162 [TBL] [Abstract][Full Text] [Related]
15. Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. Bleharski JR; Niazi KR; Sieling PA; Cheng G; Modlin RL J Immunol; 2001 Sep; 167(6):3174-81. PubMed ID: 11544303 [TBL] [Abstract][Full Text] [Related]
16. Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling. Tam RC; Lim C; Bard J; Pai B J Immunol; 1999 Oct; 163(7):3709-17. PubMed ID: 10490966 [TBL] [Abstract][Full Text] [Related]
17. Role of CD28/B7 costimulation in the dexamethasone-induced suppression of IFN-gamma. Agarwal SK; Marshall GD J Interferon Cytokine Res; 2000 Nov; 20(11):927-34. PubMed ID: 11096449 [TBL] [Abstract][Full Text] [Related]
18. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias. Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta. Hussien Y; Sanna A; Söderström M; Link H; Huang YM Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948 [TBL] [Abstract][Full Text] [Related]
20. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. Gorczynski L; Chen Z; Hu J; Kai Y; Lei J; Ramakrishna V; Gorczynski RM J Immunol; 1999 Jan; 162(2):774-81. PubMed ID: 9916698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]